Amarin Corp Plc (AMRN)

[couldbebetter]

Maybe JT could announce that he hired an investment banking firm to
explore alternatives including a sale of the company. According to JT
in a year or two, Europe will have over 100 million people with CVD.

The Evaporate Trial may help to explain why it is important to stay on
Vascepa for as long as possible or to start it as early as possible
because the longer one is on it the greater the reduction of plaque.
Imagine using that fact to get doctors familiar with Vascepa. Each
1% of that 100 million people in Europe with CVD should bring in at
least $1 billion. Only 2% of the market there should justify a BO
value of $9 billion. Divide that by 415 million fully diluted shares
and it comes out to $21.68 a share. In reality BP would end up doing
far more than $2 billion based on Europe alone.

What is the value for COVID-19, for our agreement with Edingpharm for
China. (Massive market potential.) Our agreement calls for AMRN
to provide the drug or the raw material. A BP should like that!
Canada is all set! What about all the rest of the world? CVD
continues to be the worlds biggest killer and AMRN has a proven
therapy! Our market cap is UNDER $2 billion...INSANE!